Nurse-administered and self-administered screening techniques can show different results. People with SCD are at a “high risk of hospitalization and mortality from COVID-19." RBC survival data may “inform hemoglobin composition thresholds required to reverse the phenotype after gene therapy." Acute pain vaso-occlusive episodes are the top cause of emergency department visits among people with SCD. Researchers said involving patients "is essential to improve participation and meet the real needs of the patient ... Learn what nurses can do to help caregivers feel empowered in their role throughout the process. FDA officials called exagamglogene autotemcel and lovotibeglogene autotemcel “milestone treatments” for SCD. An ASH speaker shares his insights on what clinicians and researchers are doing to minimize GVHD risks. Glutamine is FDA approved for the treatment of acute symptoms of sickle cell disease. Why isn’t medication adherence ... Interprofessional team-based care is the standard for patients undergoing HSCT. But who belongs on the team? Literature on patient/family-provider communication in SCD is scarce, but it can be a key driver of health care quality. Patients with hematologic malignancies who may require blood transfusions may not be able to enroll in hospice care. This clinical outcome translates to meaningful improvement in health-related quality of life, according to researchers. Researchers evaluated the effects of etavopivat in two-week multiple ascending dose cohorts and a 12-week open-label study. Researchers found no increased risk for acute deep vein thrombosis post-vaccination for approved COVID-19 vaccines. Lead author Jacqueline N. Poston, MD, shared the findings. The present analysis updates findings from the ongoing phase 1/2 HGB-206 study. Researchers described the outcomes for pregnant women with SCD, who are considered at high risk for complications. Healthcare providers may struggle with the decision to recommend hematopoietic cell transplantation (HCT) for children with ... According to recent report in PLoS One, Medicaid enrollees who have sickle cell disease (SCD) are a high-need, high-cost ...